It is a pharma private limited company based in Bhubaneswar, Orissa, India, established in 2020.
2020 | Bhubaneswar, Orissa, India | ActiveSangye Menla Pharmaceuticals Private Limited, a active private limited company, was established on 09 December 2020 in Bhubaneswar, Orissa, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24296OR2020PTC035040. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 M.
Its leadership includes Dharitri Patnaik (Director), Manoranjan Rout (Director), Parthiv Surendra Mehta (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.Ga-62 Gayatri Vihar,Patia, Bhubaneswar, Orissa, 751024.
U24296OR2020PTC035040
035040
09 December 2020
₹2.00 Cr
₹1.00 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Sangye Menla Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dharitri Patnaik | Director | 09 Dec 2020 | Current |
| Manoranjan Rout | Director | 09 Dec 2020 | Current |
| Parthiv Surendra Mehta | Director | 09 Dec 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sangye Menla Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 398.55% decrease in profit. The company's net worth dipped by a decrease of 1.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sangye Menla Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sangye Menla Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sangye Menla Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sangye Menla Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sangye Menla Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Sangye Menla Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack. was documented.
Dharitri Patnaik was appointed as a Director was appointed as a Director on 09 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Manoranjan Rout was appointed as a Director was appointed as a Director on 09 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Parthiv Surendra Mehta was appointed as a Director was appointed as a Director on 09 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
The activity Sangye Menla Pharmaceuticals Private Limited was registered on 09 Dec 2020 with Roc Cuttack & aged 4 years 11 months as per MCA records. was completed.
The CIN of Sangye Menla Pharmaceuticals Private Limited is U24296OR2020PTC035040.
Sangye Menla Pharmaceuticals Private Limited is headquartered at Plot No.Ga-62 Gayatri Vihar,Patia, Bhubaneswar, Orissa, 751024.
Sangye Menla Pharmaceuticals Private Limited was incorporated on 09 December 2020.
The current directors of Sangye Menla Pharmaceuticals Private Limited are
The primary industry of Sangye Menla Pharmaceuticals Private Limited is Pharma.
Sangye Menla Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sangye Menla Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX